/PRNewswire/ PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions today announced a clinical research study with.
The next destination on our World of Genomics tour is the island nation of Cyprus. Kípros in Greek and Kıbrıs in Turkish, Cyprus is found in the eastern Mediterranean Sea. Geographically, the island is located in Asia, but Cyprus is actually part of Europe and shares cultural elements from both continents. Having been inhabited for more than 10 millennia, the country has soaked up the culture, languages and history of generations of conquerors, pilgrims and travellers.
Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune connective-tissue
disease. Once considered an untreatable and unpredictable condition, research advancements
have improved our understanding of its disease pathogenesis and clinical phenotypes
and expanded our treatment armamentarium. Early and accurate diagnosis is essential,
while ongoing efforts to risk stratify patients have a central role in predicting
both organ involvement and disease progression. A holistic approach is required when
choosing the optimal therapeutic strategy, balancing the side-effect profile with
efficacy and tailoring the treatment according to the goals of care of the patient.